Definitive Healthcare Corp. DH
Our mission is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow's healthcare industry. Our software-as-a-service ("SaaS") platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next.
Definitive Healthcare is a leading provider of healthcare data and analytics. We provide accurate, comprehensive information on healthcare providers and their activities, enabling customers to make informed decisions across product development, go-to-market planning, and sales and marketing execution. We also offer claims and consumer analytics built from modeled data on millions of unique consumers to help healthcare organizations target, message, and engage specific healthcare audiences.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- United States
- Rest of world
| Region | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| United States | $224.4M | $241.8M | $239.5M |
| Rest of world | $17.2M | $10.4M | $12.0M |
As the company reported it, from the “Segment and Geographic Data - Schedule of Revenue by Geographic Areas (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $241.5M | $252.2M | $251.4M | $222.7M | $166.2M | $118.3M | — | — |
| Cost of revenue | $58.2M | $54.7M | $47.5M | $42.6M | — | — | — | — |
| Gross profit | $183.3M | $197.5M | $203.9M | $180.0M | $125.5M | $87.8M | — | — |
| R&D | $34.8M | $36.5M | $42.4M | $34.9M | $18.6M | $11.1M | — | — |
| SG&A | $51.6M | $49.3M | $58.9M | $51.6M | $32.9M | $14.4M | — | — |
| Total operating expenses | $407.5M | $908.3M | $533.7M | $224.1M | $152.8M | $103.7M | — | — |
| Operating income | -$224.3M | -$710.8M | -$329.8M | -$44.0M | -$27.3M | -$15.9M | — | — |
| Interest expense | $11.3M | $14.8M | $15.2M | $11.2M | $25.9M | $36.5M | — | — |
| Pre-tax income | -$209.3M | -$633.7M | -$308.2M | -$41.9M | -$62.8M | -$52.6M | — | — |
| Income tax | $10.0M | $42.3M | $18.6M | $17.7M | $443.0K | $0 | — | — |
| Net income | -$199.3M | -$591.4M | -$289.6M | -$7.2M | -$17.8M | $0 | — | — |
| EPS, basic | -1.30 | -3.54 | -1.79 | -0.07 | -0.19 | — | — | — |
| EPS, diluted | -1.30 | -3.54 | -1.79 | -0.07 | -0.19 | — | — | — |
| Shares, diluted (wtd. avg.) | 106.7M | 116.6M | 112.8M | 101.1M | 91.9M | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $163.6M | $105.4M | $131.0M | $146.9M | $387.5M | $24.8M | $8.6M | $19.4M |
| Short-term investments | $17.3M | $184.8M | $177.1M | $184.9M | $0 | — | — | — |
| Receivables | $52.0M | $53.2M | $59.2M | $58.8M | $43.3M | $33.1M | — | — |
| Total current assets | $257.6M | $370.2M | $393.9M | $413.7M | $444.2M | $63.8M | — | — |
| Property, plant and equipment | $12.7M | $3.8M | $4.5M | $4.5M | $5.1M | $3.2M | — | — |
| Goodwill | $197.2M | $393.3M | $1.08B | $1.32B | $1.26B | $1.26B | — | — |
| Other intangibles | $247.5M | $297.9M | $323.1M | $350.7M | $352.5M | $410.2M | — | — |
| Total assets | $735.5M | $1.09B | $1.83B | $2.12B | $1.73B | $1.75B | — | — |
| Accounts payable | $3.6M | $10.8M | $5.8M | $3.9M | $4.7M | $5.7M | — | — |
| Short-term debt | $8.8M | $13.8M | $13.8M | $8.6M | $6.9M | $4.7M | — | — |
| Total current liabilities | $156.8M | $161.2M | $170.7M | $140.6M | $102.4M | $97.2M | $97.8M | — |
| Long-term debt | $156.1M | $229.4M | $242.6M | $255.8M | $263.8M | $457.2M | — | — |
| Total liabilities | $356.5M | $482.2M | $626.7M | $640.7M | $560.1M | $554.4M | — | — |
| Retained earnings | -$779.5M | -$640.6M | -$227.4M | -$25.1M | -$17.8M | — | — | — |
| Total equity | $379.0M | $607.2M | $1.20B | $1.48B | $1.17B | $1.19B | $1.20B | — |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $53.8M | $58.2M | $41.2M | $35.6M | $25.2M | $23.2M | — | — |
| Depreciation and amortisation | $3.3M | $2.2M | $2.0M | $2.2M | $1.8M | $1.2M | — | — |
| Stock-based compensation | $29.1M | $38.1M | $48.7M | $36.4M | $10.0M | $1.7M | — | — |
| Capital expenditure | $16.7M | $12.3M | $3.0M | $8.3M | $6.7M | $1.4M | — | — |
| Investing cash flow | $153.9M | -$26.4M | -$31.8M | -$248.9M | -$46.7M | -$23.9M | — | — |
| Financing cash flow | -$150.8M | -$56.7M | -$25.6M | -$26.7M | $384.4M | $16.7M | — | — |
| Buybacks | $49.5M | $22.4M | $0 | $0 | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-173661.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $118.3M | $166.2M | $222.7M | $251.4M | $252.2M | $241.5M |
| Gross profit | — | — | $87.8M | $125.5M | $180.0M | $203.9M | $197.5M | $183.3M |
| Net income | — | — | $0 | -$17.8M | -$7.2M | -$289.6M | -$591.4M | -$199.3M |
Recent filings and events
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Results announced Item 2.02
- Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02
- Officer or director change Item 5.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Results announced Item 2.02
- Results announced Item 2.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 7372
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MSFT | MICROSOFT CORP | $3.89T | 29.2x | 17.8% |
| PLTR | Palantir Technologies Inc. | $472.16B | 312.3x | 56.2% |
| ORCL | ORACLE CORP | $363.40B | 21.6x | 17.3% |
| CRWD | CrowdStrike Holdings, Inc. | $263.73B | — | 21.7% |
| SHOP | SHOPIFY INC. | $218.48B | 179.4x | 30.1% |
| CRM | Salesforce, Inc. | $204.57B | 31.9x | 9.6% |
| NOW | ServiceNow, Inc. | $164.36B | 95.2x | 20.9% |
| NET | Cloudflare, Inc. | $115.42B | — | 29.8% |